Pura Vida Investments, LLC Viking Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $693,703 - $3.77 Million	39,868 New	39,868 $3.27 Million
Q3 2018 Nov 14, 2018	SELL	$9.7 - $19.65 $456,869 - $925,514	-47,100 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$3.88 - $12.74 $495,747 - $1.63 Million	-127,770 Reduced 73.07%	47,100 $447,000
Q1 2018 May 14, 2018	SELL	$4.11 - $6.93 $1.06 Million - $1.8 Million	-259,030 Reduced 59.7%	174,870 $0
Q4 2017 Feb 14, 2018	BUY	$1.74 - $4.34 $754,986 - $1.88 Million	433,900	433,900 $0

474

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.18B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.